MX9707673A - Derivados de ureido biologicamente activos, eficaces en el tratamiento de la esclerosis multiple. - Google Patents

Derivados de ureido biologicamente activos, eficaces en el tratamiento de la esclerosis multiple.

Info

Publication number
MX9707673A
MX9707673A MX9707673A MX9707673A MX9707673A MX 9707673 A MX9707673 A MX 9707673A MX 9707673 A MX9707673 A MX 9707673A MX 9707673 A MX9707673 A MX 9707673A MX 9707673 A MX9707673 A MX 9707673A
Authority
MX
Mexico
Prior art keywords
treatment
multiple sclerosis
biologically active
derivatives useful
ureido derivatives
Prior art date
Application number
MX9707673A
Other languages
English (en)
Other versions
MXPA97007673A (es
Inventor
Rachele Alzani
Elena Cozzi
Nicola Mongelli
Andrea Lombardi Borgia
Massimo Temponi
Francesco Colotta
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Publication of MX9707673A publication Critical patent/MX9707673A/es
Publication of MXPA97007673A publication Critical patent/MXPA97007673A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Empleo, en la preparacion de un medicamento para uso en el tratamiento de esclerosis multiple, de un compuesto el cual es un derivado ureido de la formula (I) en donde cada m y n, son los mismos, como un numero entero de 1 a 3; y cada uno de los grupos R, en el cual son los mismos, es un grupo naftilo substituido por 1 a 3 grupos de ácido sulfonico, o una sal de la misma farmacéuticamente aceptable.
MXPA/A/1997/007673A 1996-02-09 1997-10-06 Derivados de ureido biologicamente activos, eficaces en el tratamiento de la esclerosis multiple MXPA97007673A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9602721.4A GB9602721D0 (en) 1996-02-09 1996-02-09 Biologically active ureido derivatives useful in the treatment of multiple sclerosis
GB9602721.4 1996-02-09
PCT/EP1997/000412 WO1997028796A1 (en) 1996-02-09 1997-01-24 Biologically active ureido derivatives useful in the treatment of multiple sclerosis

Publications (2)

Publication Number Publication Date
MX9707673A true MX9707673A (es) 1997-11-29
MXPA97007673A MXPA97007673A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
ATE189388T1 (de) 2000-02-15
WO1997028796A1 (en) 1997-08-14
DE69701243T2 (de) 2000-09-07
NO974651L (no) 1997-12-02
IL121808A0 (en) 1998-02-22
JPH11504041A (ja) 1999-04-06
PT820284E (pt) 2000-07-31
ZA97902B (en) 1997-08-01
PL322717A1 (en) 1998-02-16
EP0820284B1 (en) 2000-02-02
AU1720097A (en) 1997-08-28
EA000166B1 (ru) 1998-10-29
EA199700302A1 (ru) 1998-04-30
ES2144844T3 (es) 2000-06-16
KR19980703718A (ko) 1998-12-05
GB9602721D0 (en) 1996-04-10
HUP9900796A2 (hu) 1999-07-28
CA2217008A1 (en) 1997-08-14
NO974651D0 (no) 1997-10-08
US5859046A (en) 1999-01-12
AR005724A1 (es) 1999-07-14
BR9702075A (pt) 1998-06-09
DE69701243D1 (de) 2000-03-09
DK0820284T3 (da) 2000-07-24
GR3033332T3 (en) 2000-09-29
EP0820284A1 (en) 1998-01-28

Similar Documents

Publication Publication Date Title
EA199600104A1 (ru) Повышенная биодоступность биологически активных соединений при связывании с производными полипирролкарбоксамидонафталиновой кислоты
MD1233B1 (en) Erythromycin derivatives, process for their preparation and pharmaceutical composition on base thereof
SE9504661D0 (sv) New compounds
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
AU2905092A (en) Pharmaceutical dipeptide compositions and methods of use thereof
MX9504381A (es) Derivados de ureido de acidos naftalenfosfonicos y procesos para su preparacion.
HUT61780A (en) Process for producing new peptides and pharmaceutical compositions comprising same as active ingredient
ES2160602T3 (es) Derivados de quinolona y acridinona para el tratamiento de la incontinencia urinaria.
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
UA42733C2 (uk) Похідні біснафталіміду та їх фармацевтично прийнятні кислотно-адитивні солі, фармацевтична композиція з цитотоксичною активністю, яка їх містить
ES2097736T3 (es) Peptido ciclico con actividad antagonista de sustancia p y sustancia k.
BG60101B2 (bg) Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол
MY110004A (en) Biologically active ureido derivatives useful as antimetastatic agents.
HUT70531A (en) Arylmorpholine derivatives, pharmaceutical compositions containing them as active agent and process for preparing them
ATE310010T1 (de) 6-0-substitutierte eryththromycin-verbindungen und verfahrenen zu ihrer herstellung
AU8226891A (en) Benzopyran derivative, production thereof, and pharmaceutical composition containing the same
SE9504662D0 (sv) New compounds
EA199700302A1 (ru) Биологически активные уреидо-производные, полезные при лечении рассеянного склероза
EP1027051A4 (en) ANTITHROMBOTIC AGENTS
CA2038025A1 (en) Optically active alkylenedioxybenzene derivatives and their use in therapy
ATE89549T1 (de) Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
EA200000374A2 (ru) Новые соединения 2,3-метаноаминокислоты, способ их получения и содержащие их фармацевтические композиции
NZ503027A (en) Use of rifamycin derivative for treating mastitis in a domestic animal
RU94046312A (ru) Применение биологически активных уреидопроизводных для лечения индуцируемых лентивирусами заболеваний, продукты, содержащие уреидопроизводные